ATX
Click for more information
0.00% 6.4¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-10

  1. vrs37
    437 Posts.
    lightbulb Created with Sketch. 211
    clock Created with Sketch.
    27/03/24
    18:08
    Post #: 73089035
    mpact is the name of the p3 trial that showed adding abraxane to gemcitabine increased median survival over gemcitabine by itself. It’s published. Yes abraxane was approved in pancreatic cancer based on mpact.
    ATX Price at posting: 7.7¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
NEWS Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within
right-arrow Created with Sketch.
1CG OneClick surpasses 150,000 registered users
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.38M
Open High Low Value Volume
6.3¢ 6.4¢ 6.3¢ $3.016K 47.79K

Buyers (Bids)

No. Vol. Price($)
2 217306 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 37701 1
View Market Depth
Last trade - 15.59pm 18/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.